Two decades after BRCA: Setting paradigms in personalized cancer care and prevention

Science

Volumn 343, Issue 6178, 2014, Pages 1466-1470

  Couch, Fergus J ^a   Nathanson, Katherine L ^b   Offit, Kenneth ^c,d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRCA1 PROTEIN, HUMAN;

CANCER; CLONE; DECADAL VARIATION; GENOMICS; MUTATION; PATHOGENICITY;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LANDSCAPE; MASTECTOMY; MOLECULAR CLONING; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION; GENETICS; MUTATION; PERSONALIZED MEDICINE;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CLONING, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MUTATION; PRECISION MEDICINE;

EID: 84896995635     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1251827     Document Type: Review

References (94)

1. Collaborative Group on Hormonal Factors in Breast Cancer, Lancet 358, 1389-1399 (2001).
2. Y. Miki et al., Science 266, 66-71 (1994).
3. R. Wooster et al., Nature 378, 789-792 (1995).
4. M.-C. King, Science 343, 1462-1465 (2014).
5. O. G. Bahcall, Nat. Genet. 45, 343 (2013).
6. A. C. Antoniou et al., Br. J. Cancer 98, 1457-1466 (2008).
7. N. Mavaddat, A. C. Antoniou, D. F. Easton, M. Garcia-Closas, Mol. Oncol. 4, 174-191 (2010).
8. J. Peto et al., J. Natl. Cancer Inst. 91, 943-949 (1999).
9. L. H. Castilla et al., Nat. Genet. 8, 387-391 (1994).
10. P. A. Futreal et al., Science 266, 120-122 (1994).
11. L. Guidugli et al., Hum. Mutat. 35, 151-164 (2014).
12. L. Guidugli et al., Cancer Res. 73, 265-275 (2013).
13. T. Judkins et al., Cancer 118, 5210-5216 (2012).
14. C. Oddoux et al., Nat. Genet. 14, 188-190 (1996).
15. B. B. Roa, A. A. Boyd, K. Volcik, C. S. Richards, Nat. Genet. 14, 185-187 (1996).
16. A. Petrij-Bosch et al., Nat. Genet. 17, 341-345 (1997).
17. J. N. Weitzel et al., J. Clin. Oncol. 31, 210-216 (2013).
18. K. Offit, J. Natl. Cancer Inst. 98, 1675-1677 (2006).
19. S. Chen, G. Parmigiani, J. Clin. Oncol. 25, 1329-1333 (2007).
20. S. A. Gayther et al., Nat. Genet. 11, 428-433 (1995).
21. S. A. Gayther et al., Am. J. Hum. Genet. 60, 1239-1242 (1997).
22. D. Thompson, D. Easton; Breast Cancer Linkage Consortium, Am. J. Hum. Genet. 68, 410-419 (2001).
23. A. C. Antoniou et al., Cancer Res. 70, 9742-9754 (2010).
24. A. C. Antoniou et al., Hum. Mol. Genet. 20, 3304-3321 (2011).
25. T. R. Rebbeck et al., Cancer Res. 71, 5792-5805 (2011).
26. M. M. Gaudet et al., PLOS Genet. 6, e1001183 (2010).
27. F. J. Couch et al., PLOS Genet. 9, e1003212 (2013).
28. M. M. Gaudet et al., PLOS Genet. 9, e1003173 (2013).
29. X. Wang et al., Hum. Mol. Genet. 19, 2886-2897 (2010).
30. A. B. Spurdle et al., J. Med. Genet. 49, 525-532 (2012).
31. S. V. Tavtigian, G. B. Byrnes, D. E. Goldgar, A. Thomas, Hum. Mutat. 29, 1342-1354 (2008).
32. D. E. Goldgar et al., Am. J. Hum. Genet. 75, 535-544 (2004).
33. N. M. Lindor et al., Hum. Mutat. 33, 8-21 (2012).
34. M. S. Lee et al., Cancer Res. 70, 4880-4890 (2010).
35. K. Biswas et al., Hum. Mol. Genet. 21, 3993-4006 (2012).
36. P. Bouwman et al., Cancer Discov 3, 1142-1155 (2013).
37. E. S. Iversen Jr., F. J. Couch, D. E. Goldgar, S. V. Tavtigian, A. N. Monteiro, Cancer Epidemiol. Biomarkers Prev. 20, 1078-1088 (2011).
38. S. Chang et al., Nat. Med. 17, 1275-1282 (2011).
39. K. Michailidou et al., Nat. Genet. 45, 353-361 (2013).
40. M. Robson, K. Offit, N. Engl. J. Med. 357, 154-162 (2007).
41. K. Collett et al., Cancer Epidemiol. Biomarkers Prev. 14, 1108-1112 (2005).
42. M. Kriege et al., N. Engl. J. Med. 351, 427-437 (2004).
43. E. Warner et al., JAMA 292, 1317-1325 (2004).
44. M. O. Leach et al., Lancet 365, 1769-1778 (2005).
45. C. K. Kuhl et al., J. Clin. Oncol. 23, 8469-8476 (2005).
46. C. D. Lehman et al., Cancer 103, 1898-1905 (2005).
47. F. Sardanelli et al., Radiology 242, 698-715 (2007).
48. T. R. Rebbeck et al., J. Clin. Oncol. 22, 1055-1062 (2004).
49. S. M. Domchek et al., JAMA 304, 967-975 (2010).
50. K. A. Metcalfe et al ., Int. J. Cancer 122, 2017-2022 (2008).
51. B. B. J. Hermsen et al., Br. J. Cancer 96, 1335-1342 (2007).
52. R. I. Olivier, M. A. C. Lubsen-Brandsma, S. Verhoef, M. van Beurden, Gynecol. Oncol. 100, 20-26 (2006).
53. A. Finch et al., JAMA 296, 185-192 (2006).
54. N. D. Kauff et al., N. Engl. J. Med. 346, 1609-1615 (2002).
55. T. R. Rebbeck et al., N. Engl. J. Med. 346, 1616-1622 (2002).
56. A. Eisen et al., J. Clin. Oncol. 23, 7491-7496 (2005).
57. K. Offit, Hum. Genet. 130, 3-14 (2011).
58. M. C. King et al., JAMA 286, 2251-2256 (2001).
59. J. Gronwald et al., Int. J. Cancer 118, 2281-2284 (2006).
60. J. R. McLaughlin et al., Lancet Oncol. 8, 26-34 (2007).
61. S. A. Narod et al., N. Engl. J. Med. 339, 424-428 (1998).
62. R. W. Haile et al., Cancer Epidemiol. Biomarkers Prev. 15, 1863-1870 (2006).
63. S. A. Narod et al., J. Natl. Cancer Inst. 94, 1773-1779 (2002).
64. M. E. Robson, J. Clin. Oncol. 29, 3724-3726 (2011).
65. H. Farmer et al., Nature 434, 917-921 (2005).
66. H. E. Bryant et al., Nature 434, 913-917 (2005).
67. S. B. De Lorenzo, A. G. Patel, R. M. Hurley, S. H. Kaufmann, Front Oncol 3, 228 (2013).
68. N. Curtin, Biochem. Soc. Trans. 42, 82-88 (2014).
69. R. Drost et al., Cancer Cell 20, 797-809 (2011).
70. E. M. Rosen, M. J. Pishvaian, Curr. Drug Targets 15, 17-31 (2014).
71. C. J. Lord, A. Ashworth, Nat. Med. 19, 1381-1388 (2013).
72. S. L. Edwards et al., Nature 451, 1111-1115 (2008).
73. C. C. Wu, S. Shete, C. I. Amos, L. C. Strong, Cancer Res. 66, 8287-8292 (2006).
74. V. Bubien et al., J. Med. Genet. 50, 255-263 (2013).
75. N. Hearle et al., Clin. Cancer Res. 12, 3209-3215 (2006).
76. N. Rahman et al., Nat. Genet. 39, 165-167 (2007).
77. S. M. Domchek, A. Bradbury, J. E. Garber, K. Offit, M. E. Robson, J. Clin. Oncol. 31, 1267-1270 (2013).
78. C. Loveday et al., Nat. Genet. 44, 475-476 (2012).
79. K. P. Pennington et al., Clin. Cancer Res. 20, 764-775 (2014).
80. K. N. Maxwell, K. L. Nathanson, Breast Cancer Res. 15, 212 (2013).
81. K. B. Meyer et al., Am. J. Hum. Genet. 93, 1046-1060 (2013).
82. M. Garcia-Closas et al., Nat. Genet. 45, 392-398, e1-e2 (2013).
83. K. N. Stevens et al., Cancer Res. 72, 1795-1803 (2012).
84. C. A. Haiman et al., Nat. Genet. 43, 1210-1214 (2011).
85. K. S. Purrington et al., Carcinogenesis 35, bgt404 (2014).
86. J. D. French et al., Am. J. Hum. Genet. 92, 489-503 (2013).
87. S. Wacholder et al., N. Engl. J. Med. 362, 986-993 (2010).
88. S. Sawyer et al., J. Clin. Oncol. 30, 4330-4336 (2012).
89. Z. K. Stadler et al., Hematol. Oncol. Clin. North Am. 24, 973-996 (2010).
90. Z. K. Stadler, K. A. Schrader, J. Vijai, M. E. Robson, K. Offit, J. Clin. Oncol. 32, 687-698 (2014).
91. N. Pashayan et al., J. Intern. Med. 274, 451-456 (2013).
92. A. E. Hall et al., J. Public Health 2013, fdt078 (2013).
93. K. Offit, M. E. Robson, J. Clin. Oncol. 28, 4665-4666 (2010).
94. Y. Bombard, M. Robson, K. Offit, JAMA 310, 795-796 (2013).